Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Radiographic patterns and response to corticosteroid hip injection

Article Abstract:

Corticosteroid hip injections (CHIs) for arthritic patients appear to provide pain relief and rotational improvement for up to 12 weeks. Methylprednisolone and lignocaine were injected into the hips of 45 patients with either osteoarthritis, rheumatoid arthritis, or ankylosing spondylitis. Patients in all groups except those with bone wasting disease reported significant improvement in pain relief two weeks after the CHI, particularly at night. Pain relief persisted 12 wks after the CHI but began to diminish. Pain levels at 26 wks were similar to initial levels. Joint rotation improvement followed a similar cyclic pattern.

Author: Dawes, P.T., Plant, M.J., Borg, A.A., Dziedzic, K., Saklatvala, J.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1997
Health aspects, Corticosteroids, Adrenocortical hormones, Injections, Intra-arterial, Intra-arterial injections

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Use of complementary medicines for osteoarthritis: A prospective study

Article Abstract:

An investigation is made of 341 patients suffering from osteoarthritis of the knee or hip down, undergoing complementary and alternative medicines. A need is expressed for patient education on the risks and benefits of complementary and alternative medication.

Author: Brooks, P., Zochling, J., March, L. M., Lapsley, H., Cross, M., Tribe, K.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2004
Science & research, HEALTH SERVICES, Ambulatory Health Care Services, Therapeutic Procedures, Research, Therapeutics, Alternative medicine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Insulin-like growth factor I gene promoter polymorphism, collagen type II alpha 1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam study

Article Abstract:

The main aim of this study is to identify the role of insulin-like growth factor I in the prevalence of radiographic osteoarthritis. Insulin-like growth factor I is a polypeptide mediator with a potent anabolic impact on cartilage homeostasis.

Author: Zhai, G., Rivadeneira, F., Houwing-Duistermaat, J.J., Meulenbelt, I., Bijkerk, C., Hofman, A., Meurs, J.B.J. van, Uitterlinden, A. G., Pols, H.A.P., Slagboom, P.E., Duijn, C.M. van
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2004
Insulin-like growth factor 1, Insulin-like growth factor I

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Evaluation, Osteoarthritis, United States
Similar abstracts:
  • Abstracts: Bedside manners. Interventions to reduce clostridium difficile infection. Jont venture: inviting patients to have say during the report handover session encourages abalanced approach to care
  • Abstracts: Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. The early years of HIV research: integrating clinical and basic research
  • Abstracts: Different in world responses to natural disasters and complex emergencies. Asthma prevalence and control characteristics by race/ethnicity - United States, 2002
  • Abstracts: Cdk5-dependent regulation of glucose-stimulated insulin secretion. A new cell-permeable peptide allows successful allogeneric islet transplantation in mice
  • Abstracts: Is advanced maternal age an independent risk factor for uteroplacental insufficiency? Assessment of the facial features and chins development of fetuses with the use of serial three-dimensional sonography and mandibular size monogram in a Chinese population
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.